|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.761
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.739
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.738
|
|
|
|
positive regulation of cytosolic calcium ion concentration involved in phospholipase c activating g protein coupled signaling pathway
|
GO:0051482 |
4 |
0.716
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.669
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.664
|
|
|
|
endocrine system development
|
GO:0035270 |
98 |
0.635
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.618
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.593
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.588
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.587
|
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.586
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.554
|
Mouse |
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.548
|
Mouse |
|
|
ovarian follicle development
|
GO:0001541 |
40 |
0.544
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.539
|
Mouse |
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.538
|
|
|
|
mesendoderm development
|
GO:0048382 |
3 |
0.499
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.468
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.450
|
|
|
|
positive regulation of extrinsic apoptotic signaling pathway via death domain receptors
|
GO:1902043 |
13 |
0.443
|
|
|
|
alpha beta t cell differentiation
|
GO:0046632 |
69 |
0.440
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.429
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.428
|
Mouse |
|
|
urogenital system development
|
GO:0001655 |
261 |
0.422
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.416
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.410
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.409
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.407
|
|
|
|
positive regulation of epithelial cell proliferation
|
GO:0050679 |
68 |
0.407
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.404
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.392
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.388
|
|
|
|
regulation of bmp signaling pathway
|
GO:0030510 |
60 |
0.387
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.383
|
|
|
|
purine containing compound biosynthetic process
|
GO:0072522 |
70 |
0.383
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.379
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.377
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.374
|
|
|
|
mesenchymal cell differentiation
|
GO:0048762 |
107 |
0.371
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.369
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.368
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.367
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.365
|
|
|
|
generation of precursor metabolites and energy
|
GO:0006091 |
103 |
0.364
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.359
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.357
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.352
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.351
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.344
|
|
|
|
metencephalon development
|
GO:0022037 |
89 |
0.344
|
|
|
|
lateral mesoderm morphogenesis
|
GO:0048369 |
3 |
0.338
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.337
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.328
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.326
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.326
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.325
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.322
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.322
|
|
|
|
lung alveolus development
|
GO:0048286 |
45 |
0.320
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.319
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.318
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.317
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.315
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.313
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.311
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.309
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.309
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.301
|
|
|
|
ovulation cycle
|
GO:0042698 |
59 |
0.295
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.295
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.293
|
Rat |
|
|
regulation of hormone secretion
|
GO:0046883 |
88 |
0.293
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.293
|
|
|
|
peptide hormone secretion
|
GO:0030072 |
109 |
0.291
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.291
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.291
|
Rat |
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.288
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.286
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.286
|
|
|
|
learning or memory
|
GO:0007611 |
148 |
0.285
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.285
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.284
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.284
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.282
|
|
|
|
positive regulation of endothelial cell proliferation
|
GO:0001938 |
17 |
0.281
|
|
|
|
single organism nuclear import
|
GO:1902593 |
95 |
0.279
|
|
|
|
fused antrum stage
|
GO:0048165 |
1 |
0.278
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.278
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.272
|
|
|
|
anatomical structure arrangement
|
GO:0048532 |
20 |
0.270
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.269
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.268
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.267
|
|
|
|
female sex differentiation
|
GO:0046660 |
84 |
0.264
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.263
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.262
|
|
|
|
regulation of protein binding
|
GO:0043393 |
60 |
0.261
|
Rat |
|
|
regulation of heart contraction
|
GO:0008016 |
77 |
0.254
|
|
|
|
trachea formation
|
GO:0060440 |
3 |
0.253
|
|
|
|
phospholipase c activating g protein coupled receptor signaling pathway
|
GO:0007200 |
26 |
0.251
|
|
|
|
g protein coupled receptor internalization
|
GO:0002031 |
3 |
0.251
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.249
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.249
|
|
|
|
adult behavior
|
GO:0030534 |
135 |
0.249
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.249
|
|
|
|
alpha beta t cell activation
|
GO:0046631 |
91 |
0.245
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.244
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.244
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.242
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.242
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
118 |
0.242
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.240
|
|
|
|
protein import into nucleus
|
GO:0006606 |
95 |
0.238
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.238
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.237
|
|
|
|
neuron projection extension involved in neuron projection guidance
|
GO:1902284 |
14 |
0.237
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.235
|
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
82 |
0.235
|
Rat |
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.231
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.231
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.227
|
|
|
|
skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration
|
GO:0014834 |
3 |
0.227
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.226
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.226
|
Mouse |
|
|
vascular process in circulatory system
|
GO:0003018 |
62 |
0.225
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.225
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.225
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.224
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.224
|
|
|
|
negative regulation of bmp signaling pathway
|
GO:0030514 |
35 |
0.224
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
96 |
0.222
|
|
|
|
trunk neural crest cell migration
|
GO:0036484 |
4 |
0.222
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.221
|
|
|
|
positive regulation of alpha beta t cell differentiation
|
GO:0046638 |
28 |
0.218
|
|
|
|
regulation of tight junction assembly
|
GO:2000810 |
2 |
0.218
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.218
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.218
|
|
|
|
positive regulation of cyclic nucleotide biosynthetic process
|
GO:0030804 |
24 |
0.217
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.216
|
|
|
|
regulation of lymphocyte differentiation
|
GO:0045619 |
107 |
0.216
|
|
|
|
syncytiotrophoblast cell differentiation involved in labyrinthine layer development
|
GO:0060715 |
2 |
0.212
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.212
|
|
|
|
progesterone secretion
|
GO:0042701 |
1 |
0.212
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.209
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.209
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.208
|
|
|
|
lateral mesodermal cell differentiation
|
GO:0048371 |
3 |
0.207
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.203
|
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.203
|
|
|
|
germ line stem cell division
|
GO:0042078 |
2 |
0.203
|
|
|
|
regulation of cartilage development
|
GO:0061035 |
44 |
0.203
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.202
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.199
|
|
|
|
growth plate cartilage chondrocyte growth
|
GO:0003430 |
2 |
0.199
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.199
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.199
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.197
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.196
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.196
|
|
|
|
positive regulation of t cell activation
|
GO:0050870 |
101 |
0.195
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.192
|
|
|
|
camp biosynthetic process
|
GO:0006171 |
31 |
0.191
|
|
|
|
cerebral cortex tangential migration using cell axon interactions
|
GO:0021824 |
3 |
0.191
|
|
|
|
response to hypoxia
|
GO:0001666 |
58 |
0.190
|
Rat |
|
|
negative regulation of endothelial cell differentiation
|
GO:0045602 |
2 |
0.188
|
|
|
|
establishment of neuroblast polarity
|
GO:0045200 |
1 |
0.187
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.186
|
|
|
|
regulation of stem cell proliferation
|
GO:0072091 |
78 |
0.186
|
|
|
|
cerebellum vasculature morphogenesis
|
GO:0061301 |
1 |
0.186
|
|
|
|
nuclear import
|
GO:0051170 |
95 |
0.186
|
|
|
|
g protein coupled receptor signaling pathway coupled to cyclic nucleotide second messenger
|
GO:0007187 |
55 |
0.185
|
|
|
|
retinal blood vessel morphogenesis
|
GO:0061304 |
3 |
0.185
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.184
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.184
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.182
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.182
|
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.181
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.181
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.181
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.179
|
|
|
|
regulation of cellular carbohydrate metabolic process
|
GO:0010675 |
75 |
0.179
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.178
|
|
|
|
cerebellum vasculature development
|
GO:0061300 |
1 |
0.177
|
|
|
|
regulation of axon guidance
|
GO:1902667 |
13 |
0.177
|
|
|
|
regulation of voltage gated calcium channel activity
|
GO:1901385 |
4 |
0.177
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.176
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.175
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.174
|
|
|
|
regulation of sodium ion transport
|
GO:0002028 |
29 |
0.173
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.173
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.172
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.171
|
|
|
|
regulation of alpha beta t cell differentiation
|
GO:0046637 |
35 |
0.169
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.169
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.169
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.168
|
|
|
|
female gonad development
|
GO:0008585 |
71 |
0.168
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.168
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.166
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.165
|
|
|
|
mammary gland morphogenesis
|
GO:0060443 |
54 |
0.165
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.165
|
|
|
|
regulation of muscle system process
|
GO:0090257 |
80 |
0.165
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.164
|
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.164
|
|
|
|
regulation of chemotaxis
|
GO:0050920 |
53 |
0.163
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.162
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.162
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
101 |
0.162
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.162
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.161
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.161
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.160
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.160
|
|
|
|
activin receptor signaling pathway
|
GO:0032924 |
18 |
0.159
|
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.159
|
|
|
|
positive regulation of t cell differentiation
|
GO:0045582 |
52 |
0.158
|
|
|
|
smoothened signaling pathway
|
GO:0007224 |
105 |
0.158
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.157
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.157
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.157
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.155
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.155
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.155
|
|
|
|
negative regulation of ossification
|
GO:0030279 |
49 |
0.154
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.154
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.153
|
|
|
|
tissue migration
|
GO:0090130 |
68 |
0.152
|
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.151
|
|
|
|
heparin biosynthetic process
|
GO:0030210 |
2 |
0.151
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.151
|
|
|
|
development of primary male sexual characteristics
|
GO:0046546 |
88 |
0.151
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.151
|
|
|
|
negative regulation of execution phase of apoptosis
|
GO:1900118 |
4 |
0.150
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.150
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.149
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.149
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.149
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.148
|
|
|
|
positive regulation of angiogenesis
|
GO:0045766 |
46 |
0.148
|
Mouse |
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.146
|
|
|
|
regulation of muscle contraction
|
GO:0006937 |
49 |
0.145
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.145
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.145
|
Mouse |
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.145
|
|
|
|
peptidyl serine phosphorylation
|
GO:0018105 |
74 |
0.144
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.144
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.144
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.144
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.143
|
|
|
|
somitogenesis
|
GO:0001756 |
69 |
0.143
|
|
|
|
histone modification
|
GO:0016570 |
159 |
0.143
|
|
|
|
positive regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090100 |
43 |
0.142
|
Rat |
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.142
|
|
|
|
lateral mesoderm formation
|
GO:0048370 |
3 |
0.141
|
|
|
|
venous blood vessel development
|
GO:0060841 |
13 |
0.141
|
Mouse |
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.141
|
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
106 |
0.141
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.140
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.140
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.140
|
|
|
|
regulation of tolerance induction to self antigen
|
GO:0002649 |
1 |
0.140
|
|
|
|
heart process
|
GO:0003015 |
94 |
0.138
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.138
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.138
|
|
|
|
endothelial cell differentiation
|
GO:0045446 |
41 |
0.137
|
|
|
|
positive regulation of stem cell proliferation
|
GO:2000648 |
59 |
0.137
|
|
|
|
positive regulation of ossification
|
GO:0045778 |
47 |
0.137
|
|
|
|
regulation of lateral mesodermal cell fate specification
|
GO:0048378 |
2 |
0.136
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.136
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.135
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.135
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.135
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.135
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.134
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.134
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.133
|
|
|
|
mesenchymal cell proliferation
|
GO:0010463 |
44 |
0.132
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.132
|
|
|
|
hypothalamus gonadotrophin releasing hormone neuron development
|
GO:0021888 |
4 |
0.132
|
|
|
|
positive regulation of epithelial cell migration
|
GO:0010634 |
19 |
0.131
|
|
|
|
energy derivation by oxidation of organic compounds
|
GO:0015980 |
77 |
0.131
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.131
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.130
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.130
|
|
|
|
cerebral cortex development
|
GO:0021987 |
86 |
0.129
|
|
|
|
regulation of transforming growth factor beta receptor signaling pathway
|
GO:0017015 |
43 |
0.129
|
Rat |
|
|
cell division
|
GO:0051301 |
120 |
0.129
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.128
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.126
|
|
|
|
regulation of endothelial cell migration
|
GO:0010594 |
22 |
0.126
|
|
|
|
b cell differentiation
|
GO:0030183 |
78 |
0.126
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.125
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.125
|
|
|
|
purine nucleotide biosynthetic process
|
GO:0006164 |
65 |
0.124
|
|
|
|
carbohydrate catabolic process
|
GO:0016052 |
32 |
0.124
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.124
|
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.124
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.124
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.124
|
|
|
|
peptidyl serine modification
|
GO:0018209 |
83 |
0.123
|
|
|
|
erk1 and erk2 cascade
|
GO:0070371 |
77 |
0.123
|
|
|
|
positive regulation of cyclic nucleotide metabolic process
|
GO:0030801 |
24 |
0.122
|
|
|
|
bronchiole development
|
GO:0060435 |
3 |
0.122
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.122
|
|
|
|
hexose metabolic process
|
GO:0019318 |
98 |
0.121
|
|
|
|
chondrocyte hypertrophy
|
GO:0003415 |
4 |
0.121
|
|
|
|
fat cell proliferation
|
GO:0070341 |
4 |
0.121
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.121
|
|
|
|
t cell differentiation in thymus
|
GO:0033077 |
77 |
0.119
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.119
|
|
|
|
positive regulation of behavior
|
GO:0048520 |
40 |
0.119
|
|
|
|
regulation of chondrocyte differentiation
|
GO:0032330 |
33 |
0.119
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.119
|
|
|
|
bone resorption
|
GO:0045453 |
38 |
0.118
|
|
|
|
memory
|
GO:0007613 |
58 |
0.118
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.118
|
|
|
|
insulin secretion
|
GO:0030073 |
89 |
0.118
|
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.117
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.116
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.116
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.116
|
Rat |
|
|
palate development
|
GO:0060021 |
76 |
0.115
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.115
|
|
|
|
adult locomotory behavior
|
GO:0008344 |
91 |
0.115
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.115
|
|
|
|
embryonic skeletal system morphogenesis
|
GO:0048704 |
91 |
0.114
|
|
|
|
bronchus morphogenesis
|
GO:0060434 |
2 |
0.112
|
|
|
|
retina vasculature development in camera type eye
|
GO:0061298 |
17 |
0.112
|
|
|
|
regulation of lipid biosynthetic process
|
GO:0046890 |
54 |
0.112
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.111
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.111
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.111
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.110
|
|
|
|
regulation of nucleocytoplasmic transport
|
GO:0046822 |
73 |
0.110
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.110
|
|
|
|
regulation of osteoblast differentiation
|
GO:0045667 |
67 |
0.110
|
|
|
|
growth plate cartilage chondrocyte development
|
GO:0003431 |
3 |
0.109
|
|
|
|
regulation of t cell differentiation
|
GO:0045580 |
83 |
0.109
|
|
|
|
lens fiber cell apoptotic process
|
GO:1990086 |
4 |
0.109
|
|
|
|
cognition
|
GO:0050890 |
149 |
0.109
|
|
|
|
lung morphogenesis
|
GO:0060425 |
50 |
0.109
|
|
|
|
polysaccharide metabolic process
|
GO:0005976 |
39 |
0.108
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.107
|
|
|
|
lung secretory cell differentiation
|
GO:0061140 |
13 |
0.107
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.107
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.107
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.106
|
|
|
|
maintenance of protein location in nucleus
|
GO:0051457 |
2 |
0.106
|
|
|
|
blood vessel remodeling
|
GO:0001974 |
33 |
0.105
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.105
|
|
|
|
negative regulation of hepatocyte differentiation
|
GO:0070367 |
1 |
0.105
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.105
|
|
|
|
artery development
|
GO:0060840 |
53 |
0.105
|
Mouse |
|
|
regulation of lung blood pressure
|
GO:0014916 |
2 |
0.104
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.104
|
|
|
|
neural crest cell development
|
GO:0014032 |
48 |
0.104
|
|
|
|
regeneration
|
GO:0031099 |
38 |
0.104
|
Rat |
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.103
|
|
|
|
asymmetric stem cell division
|
GO:0098722 |
3 |
0.102
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.101
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.101
|
|
|
|
axon extension involved in axon guidance
|
GO:0048846 |
14 |
0.101
|
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.100
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.100
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.100
|
|
|
|
organ induction
|
GO:0001759 |
21 |
0.100
|
|
|
|
forebrain cell migration
|
GO:0021885 |
58 |
0.100
|
|
|
|
spinal cord development
|
GO:0021510 |
81 |
0.100
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.099
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.099
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.099
|
|
|
|
smooth muscle contraction
|
GO:0006939 |
44 |
0.098
|
|
|
|
alpha beta t cell differentiation involved in immune response
|
GO:0002293 |
30 |
0.098
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.098
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.098
|
|
|
|
negative regulation of vasculature development
|
GO:1901343 |
26 |
0.097
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.096
|
|
|
|
feeding behavior
|
GO:0007631 |
62 |
0.096
|
|
|
|
heparin metabolic process
|
GO:0030202 |
3 |
0.096
|
|
|
|
regulation of camp metabolic process
|
GO:0030814 |
30 |
0.095
|
|
|
|
cellular glucan metabolic process
|
GO:0006073 |
32 |
0.095
|
|
|
|
positive regulation of leukocyte differentiation
|
GO:1902107 |
86 |
0.095
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.094
|
|
|
|
regulation of anti mullerian hormone signaling pathway
|
GO:1902612 |
1 |
0.094
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.094
|
|
|
|
negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090101 |
61 |
0.094
|
Rat |
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.094
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.094
|
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
74 |
0.094
|
|
|
|
regulation of smad protein import into nucleus
|
GO:0060390 |
3 |
0.094
|
|
|
|
regulation of heart growth
|
GO:0060420 |
31 |
0.094
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.093
|
|
|
|
lateral mesodermal cell fate commitment
|
GO:0048372 |
2 |
0.093
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.093
|
Mouse |
|
|
cellular polysaccharide metabolic process
|
GO:0044264 |
38 |
0.093
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.093
|
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.092
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.092
|
|
|
|
vascular endothelial growth factor receptor signaling pathway
|
GO:0048010 |
24 |
0.092
|
|
|
|
tube closure
|
GO:0060606 |
91 |
0.092
|
|
|
|
muscle cell proliferation
|
GO:0033002 |
52 |
0.091
|
|
|
|
lymphocyte activation involved in immune response
|
GO:0002285 |
93 |
0.091
|
|
|
|
embryonic genitalia morphogenesis
|
GO:0030538 |
4 |
0.091
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.090
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.090
|
|
|
|
endochondral bone morphogenesis
|
GO:0060350 |
50 |
0.089
|
|
|
|
positive regulation of lymphocyte differentiation
|
GO:0045621 |
61 |
0.088
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.088
|
|
|
|
cell junction assembly
|
GO:0034329 |
52 |
0.088
|
|
|
|
developmental cell growth
|
GO:0048588 |
84 |
0.087
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.087
|
Mouse |
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.087
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.087
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.087
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.086
|
|
|
|
cytosolic calcium ion homeostasis
|
GO:0051480 |
70 |
0.086
|
|
|
|
endochondral bone growth
|
GO:0003416 |
19 |
0.086
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.085
|
|
|
|
regulation of generation of precursor metabolites and energy
|
GO:0043467 |
38 |
0.085
|
|
|
|
regulation of cell fate commitment
|
GO:0010453 |
19 |
0.084
|
|
|
|
hindlimb morphogenesis
|
GO:0035137 |
42 |
0.084
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.084
|
|
|
|
regulation of carbohydrate metabolic process
|
GO:0006109 |
75 |
0.084
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.084
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.083
|
|
|
|
mesoderm development
|
GO:0007498 |
100 |
0.083
|
|
|
|
positive regulation of synaptic growth at neuromuscular junction
|
GO:0045887 |
1 |
0.083
|
|
|
|
paraxial mesoderm morphogenesis
|
GO:0048340 |
10 |
0.083
|
|
|
|
endothelial cell proliferation
|
GO:0001935 |
27 |
0.082
|
|
|
|
cerebellar granule cell precursor proliferation
|
GO:0021930 |
10 |
0.082
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
59 |
0.082
|
Rat |
|
|
cyclic purine nucleotide metabolic process
|
GO:0052652 |
43 |
0.082
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.082
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.081
|
|
|
|
anti mullerian hormone signaling pathway
|
GO:1990262 |
1 |
0.081
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.081
|
|
|
|
cell fate specification
|
GO:0001708 |
72 |
0.081
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.081
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.081
|
|
|
|
sympathetic neuron projection guidance
|
GO:0097491 |
4 |
0.080
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.080
|
|
|
|
development of primary female sexual characteristics
|
GO:0046545 |
73 |
0.080
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.080
|
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.080
|
|
|
|
regulation of epithelial cell migration
|
GO:0010632 |
35 |
0.080
|
|
|
|
protein import
|
GO:0017038 |
101 |
0.080
|
|
|
|
neural tube closure
|
GO:0001843 |
90 |
0.079
|
|
|
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
68 |
0.079
|
|
|
|
regulation of catenin import into nucleus
|
GO:0035412 |
5 |
0.079
|
|
|
|
establishment of planar polarity involved in neural tube closure
|
GO:0090177 |
15 |
0.078
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.078
|
|
|
|
negative regulation of systemic arterial blood pressure
|
GO:0003085 |
15 |
0.078
|
|
|
|
gonadotrophin releasing hormone neuronal migration to the hypothalamus
|
GO:0021828 |
3 |
0.078
|
|
|
|
positive regulation of erk1 and erk2 cascade
|
GO:0070374 |
47 |
0.078
|
|
|
|
vasoconstriction
|
GO:0042310 |
27 |
0.078
|
|
|
|
endocrine process
|
GO:0050886 |
39 |
0.078
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.078
|
|
|
|
regulation of protein import into nucleus
|
GO:0042306 |
52 |
0.078
|
|
|
|
cell proliferation in hindbrain
|
GO:0021534 |
10 |
0.077
|
|
|
|
white fat cell proliferation
|
GO:0070343 |
2 |
0.077
|
|
|
|
sulfur compound biosynthetic process
|
GO:0044272 |
37 |
0.077
|
|
|
|
negative regulation of blood vessel morphogenesis
|
GO:2000181 |
25 |
0.077
|
|
|
|
regulation of blood vessel size
|
GO:0050880 |
56 |
0.077
|
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
85 |
0.077
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.077
|
|
|
|
regulation of peptide transport
|
GO:0090087 |
91 |
0.077
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.077
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.077
|
|
|
|
cellular response to peptide
|
GO:1901653 |
92 |
0.076
|
|
|
|
regulation of purine nucleotide biosynthetic process
|
GO:1900371 |
34 |
0.076
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.076
|
|
|
|
positive regulation of mesenchymal cell proliferation
|
GO:0002053 |
33 |
0.076
|
|
|
|
response to cholesterol
|
GO:0070723 |
4 |
0.076
|
|
|
|
harderian gland development
|
GO:0070384 |
2 |
0.076
|
|
|
|
regulation of transporter activity
|
GO:0032409 |
57 |
0.076
|
|
|
|
adenylate cyclase modulating g protein coupled receptor signaling pathway
|
GO:0007188 |
54 |
0.076
|
|
|
|
regulation of peptide hormone secretion
|
GO:0090276 |
75 |
0.076
|
|
|
|
transforming growth factor beta receptor signaling pathway
|
GO:0007179 |
71 |
0.076
|
|
|
|
notch signaling pathway
|
GO:0007219 |
71 |
0.075
|
|
|
|
embryonic digit morphogenesis
|
GO:0042733 |
56 |
0.075
|
|
|
|
ureteric bud development
|
GO:0001657 |
94 |
0.075
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.075
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.075
|
|
|
|
muscular septum morphogenesis
|
GO:0003150 |
4 |
0.075
|
|
|
|
glycoprotein biosynthetic process
|
GO:0009101 |
89 |
0.074
|
|
|
|
negative regulation of osteoblast differentiation
|
GO:0045668 |
30 |
0.074
|
|
|
|
negative regulation of cell adhesion
|
GO:0007162 |
45 |
0.074
|
|
|
|
positive regulation of nucleotide biosynthetic process
|
GO:0030810 |
26 |
0.074
|
|
|
|
endothelial cell migration
|
GO:0043542 |
44 |
0.073
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.073
|
|
|
|
positive regulation of alpha beta t cell activation
|
GO:0046635 |
39 |
0.073
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.073
|
|
